The study of modified nucleoside contributions to RNA chemistry, structure and function has been thwarted by the lack of a site-selected method of incorporation which is both versatile and adaptable to present synthetic technologies. A reproducible and versatile site-selected incorporation of nine differently modified nucleosides into hepta- and octadecamer RNAs has been achieved with automated phosphoramidite chemistry. The 5'-O-(4,4'-dimethoxytrityl-2'-O-tert-butyldimethylsilyl-ribonucleoside-3'-O-(2- cyanoethyl-N,N-diisopropyl)phosphoramidite syntheses of m(5)C, D, psi, riboT, s(2)U, mnm(5)U, m(1)G and m(2)A were designed for compatibility with the commercially available major and 2'OH methylated ribonucleoside phosphoramidites. The synthesis of the m(5)C phosphoramidite was uniquely designed, and the first syntheses and incorporation of the two modified purine ribonucleosides are reported in detail along with that of psi, s(2)U, and mnm(5)U. Cleavage of RNA product from the synthesis support column, deprotection of the RNA, its purification by HPLC and nucleoside composition analysis are described. Modified nucleoside-containing tRNA domains were synthesized and purified in pmol quantities required for biophysical, as well as biochemical, studies. The anticodon domain of yeast tRNA(Phe) was synthesized with modified nucleosides introduced at the native positions: Cm-32, Gm(34), m(1)G(37) (precursor to Y), psi(39) and m(5)C(40). The T loop and stem was synthesized with riboT(54) and the D loop and stem with D-16 and D-17. The E coli tRNA(2)(Gln) anticodon domain was synthesized with mnm(5)U at wobble position 34, but an attempt at incorporating s(2)U at the same position failed. The unprotected thio group was labile to the oxidation step of the cyclical process. Chemically synthesized anticodon and T domains have been used in assays of tRNA structure and function (Guenther et al(1994) Biochimie 76, 1143-1151).